Wright Medical Group N.V. (WMGI) Research Coverage Started at Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of Wright Medical Group N.V. (NASDAQ:WMGI) in a research report released on Thursday, June 29th, MarketBeat Ratings reports. The firm issued an overweight rating and a $33.00 target price on the medical device company’s stock.

A number of other research analysts have also issued reports on the stock. Northcoast Research upgraded shares of Wright Medical Group N.V. from a neutral rating to a buy rating and set a $36.00 target price on the stock in a research note on Tuesday, March 21st. Bank of America Corporation lowered shares of Wright Medical Group N.V. from a buy rating to a neutral rating in a research note on Tuesday, April 11th. They noted that the move was a valuation call. BMO Capital Markets reiterated a buy rating and issued a $34.00 target price on shares of Wright Medical Group N.V. in a research note on Thursday, May 4th. Jefferies Group LLC raised their target price on shares of Wright Medical Group N.V. from $30.00 to $33.00 and gave the company a buy rating in a research note on Thursday, May 4th. Finally, Oppenheimer Holdings, Inc. set a $29.00 target price on shares of Wright Medical Group N.V. and gave the company a hold rating in a research note on Thursday, May 4th. One analyst has rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of Hold and a consensus price target of $30.40.

Shares of Wright Medical Group N.V. (WMGI) traded down 5.25% during trading on Thursday, reaching $26.88. 2,069,997 shares of the company’s stock were exchanged. The company has a 50 day moving average of $27.03 and a 200 day moving average of $27.80. Wright Medical Group N.V. has a 52-week low of $20.50 and a 52-week high of $31.53. The firm’s market capitalization is $2.79 billion.

Wright Medical Group N.V. (NASDAQ:WMGI) last posted its earnings results on Wednesday, May 3rd. The medical device company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.08) by $0.01. Wright Medical Group N.V. had a negative net margin of 63.46% and a negative return on equity of 7.30%. The firm had revenue of $177.19 million during the quarter, compared to analyst estimates of $182.42 million. Equities analysts anticipate that Wright Medical Group N.V. will post ($0.30) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.chaffeybreeze.com/2017/07/29/cantor-fitzgerald-begins-coverage-on-wright-medical-group-n-v-wmgi-updated-updated-updated.html.

In other news, VP Julie Andrews sold 1,480 shares of the firm’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $27.11, for a total transaction of $40,122.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Jennifer S. Walker sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, July 19th. The stock was sold at an average price of $28.00, for a total transaction of $560,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 40,655 shares of company stock valued at $1,116,708 over the last ninety days. 9.30% of the stock is owned by insiders.

Institutional investors have recently added to or reduced their stakes in the company. Palo Alto Investors LLC boosted its stake in shares of Wright Medical Group N.V. by 0.9% in the first quarter. Palo Alto Investors LLC now owns 2,628,193 shares of the medical device company’s stock worth $81,789,000 after buying an additional 23,600 shares during the period. Thrivent Financial for Lutherans boosted its position in Wright Medical Group N.V. by 61.6% in the fourth quarter. Thrivent Financial for Lutherans now owns 313,360 shares of the medical device company’s stock worth $7,201,000 after buying an additional 119,480 shares during the last quarter. Macquarie Group Ltd. boosted its position in Wright Medical Group N.V. by 13.3% in the fourth quarter. Macquarie Group Ltd. now owns 797,339 shares of the medical device company’s stock worth $18,323,000 after buying an additional 93,771 shares during the last quarter. Peregrine Capital Management LLC boosted its position in Wright Medical Group N.V. by 7.4% in the first quarter. Peregrine Capital Management LLC now owns 951,773 shares of the medical device company’s stock worth $29,372,000 after buying an additional 65,257 shares during the last quarter. Finally, Virginia Retirement Systems ET AL purchased a new position in Wright Medical Group N.V. during the first quarter worth $598,000.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply